Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 6.86B | 6.86B | 12.74B | 4.96B | 2.78B | 2.72B |
Gross Profit | 3.48B | 3.48B | 7.28B | 3.92B | 2.14B | 2.04B |
EBITDA | 3.50B | 3.50B | 7.95B | 4.27B | 2.36B | 1.96B |
Net Income | 65.55M | 65.78M | 4.16B | 1.82B | 906.87M | 1.06B |
Balance Sheet | ||||||
Total Assets | 77.65B | 77.65B | 72.60B | 56.12B | 48.51B | 36.50B |
Cash, Cash Equivalents and Short-Term Investments | 3.96B | 3.96B | 2.58B | 3.12B | 1.36B | 1.98B |
Total Debt | 50.88B | 50.88B | 45.22B | 34.49B | 30.05B | 19.47B |
Total Liabilities | 58.61B | 58.61B | 53.46B | 40.50B | 34.50B | 22.62B |
Stockholders Equity | 19.04B | 19.04B | 19.15B | 15.62B | 14.01B | 13.88B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -5.54B | -3.24B | -4.99B | -13.43B | -7.70B |
Operating Cash Flow | 0.00 | 553.47M | 8.60B | 3.48B | -2.43B | 219.61M |
Investing Cash Flow | 0.00 | -4.92B | -14.56B | -5.89B | -9.19B | -5.46B |
Financing Cash Flow | 0.00 | 5.49B | 5.31B | 4.23B | 10.78B | 6.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | 47.27B | 9.61 | 13.29% | 3.13% | 7.19% | 45.73% | |
79 Outperform | 47.40B | 15.89 | 9.38% | 2.11% | -0.46% | -25.32% | |
78 Outperform | 44.21B | 12.35 | 12.37% | 1.86% | 32.53% | 182.70% | |
76 Outperform | 27.17B | 10.76 | 7.81% | 4.54% | 5.49% | 17.69% | |
76 Outperform | 33.08B | 13.73 | 6.51% | 2.99% | 2.04% | -11.59% | |
58 Neutral | ¥46.76B | 531.48 | 4.27% | -61.35% | -104.58% | ||
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |